Insights provides context and perspective about key pharmacy trends and issues

IBD Treatment Options on the Rise
Specialty
Our proven strategies including step therapy, Specialty Guideline Management, and cross-benefit management can help clients better manage costs for the growing number of IBD treatments. More
Feature
Specialty
Specialty drug trend remains a critical challenge for clients across the CVS Caremark pharmacy benefit management book of business. Careful management strategies are key to effectively... More
Briefing
Specialty
AccordantCare offers a range of digital tools that have been proven to improve member engagement and outcomes, as well as a nurse-led care management model that ensures ongoing support and... More
Briefing
Specialty
CareTeams with clinical expertise and digital tools including secure messaging, apps, and wearables help improve outcomes for patients with complex or rare conditions. More
Briefing
Specialty
Patients who have rare or complex conditions benefit from personalized, in-depth care management from a team of specially trained nurses, pharmacists, social workers and clinicians. Care... More
Briefing
Specialty
CVS Health is helping ensure a better member experience by simplifying the onboarding process and getting appropriate specialty therapies to members faster. More
Briefing
Specialty
CVS Health uses its integrated model to manage specialty spend across benefits and help positively impact clinical and financial outcomes. More
Briefing
Person On Laptop
Specialty
Specialty spend continues to grow rapidly; CVS Health continues to innovate with strategies that reduced the trend impact of inflation significantly, to 1.7 percent. More
Video
Female caregiver and elderly patient discussing medical information on a couch
Specialty
Research published by Coram shows that helping patients transition to at-home or ambulatory center infusion treatments can be beneficial to both patients and payors. More
Briefing
Group of pills icon
Specialty
Key drugs to watch for in the specialty pharmacy pipeline Q4 2018–Q1 2019 More
Specialty Report